Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Healthways, Inc. (HWAY) Plunges On Guidance Cut: Hedge Funds Were Wrong About The Stock

Page 1 of 2

Healthways, Inc. (NASDAQ:HWAY) announced on Thursday that it is revising its guidance downwards for 2015, citing various reasons for the guidance cut. Some of those include a slowing business development, lower than expected revenues from health plan contracts, its Ornish reversal program, and a slowing Blue Zone project. The company set new revenue expectation for 2015 at $770 million to $785 million, a significant cut from the previous guidance of $800 million to $825 million. Healthways, Inc. (NASDAQ:HWAY) reported total revenue of $742 million in 2014. Due to the guidance cut, shares of Healthways plunged in after-hours trading last night, and are currently trading down by 20% in pre-market trading this morning.

Healthways, Inc. (NASDAQ:HWAY)

We keep an eye on hedge fund sentiment and insider sentiment to anticipate future stock performance. Many hedge fund managers have upped their holdings in Healthways, Inc. (NASDAQ:HWAY)’s stock and many have even initiated positions in the stock. By the end of Q4 2014, there were 17 hedge fund positions in the stock. But this number increased by 35% to 23 hedge fund positions in the stock by the end of Q1. This shows a strong positive hedge fund sentiment towards the stock.

Hedge funds are generally considered by investors as under performing funds, mainly due to the fact that net returns have under performed the S&P 500 for six years. This may be due to the fact that hedge funds have little option but to invest in large-cap stocks with their vast sums of capital, even though these stocks don’t deliver the same high returns that their best smaller-cap picks typically do. So why do they take on so much capital and invest in large-cap stocks? Because the more money hedge funds are managing, the more fees they collect and the more money they make. That said, most hedge funds also put great effort into analyzing and investing in small-cap stocks, these picks are simply dwarfed in size by their large-cap selections. We monitor these small-cap investments by hedge funds and came up with a small-cap strategy based on extensive research, which has managed to return 142% since August 2012 (read the details). During the same period the S&P 500 managed to return less than 60%. Our small-cap strategy has outperformed the market by around 83 percentage points in the last 33 months. This is why we feel that hedge fund activities are important.

Lets take a look at insider sentiment, another important indicator which can give us a different perspective on the stock. In the case of Healthways, Inc. (NASDAQ:HWAY), there was no insider activity (purchasing or selling) recorded in the first quarter. Insider sentiment for Healthways, Inc. (NASDAQ:HWAY) was thus neutral in the first quarter.

Let’s check out the latest action by hedge funds surrounding Healthways, Inc. (NASDAQ:HWAY).

Hedge fund activity in Healthways, Inc. (NASDAQ:HWAY)

The number of hedge funds with a position in the stock went up by 6 at the end of the first quarter, when compared to the end of Q4. This was a 35% increase in the hedge fund positions in Healthways, Inc. (NASDAQ:HWAY). This shows a strong positive hedge fund sentiment for the stock. So it is obvious that many hedge fund managers have increased their position in the stock and many have initiated a position in the stock in Q1 as well.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!